TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35212648

Group type: EXPERIMENTAL
Intervention: Inhaled lavender essence (diluted with sweet almond oil at a ratio of 1:10) administered before cannulation during 12 HD sessions.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no extra procedure performed).
Number of subjects: 24
Study: 33610374

Group type: EXPERIMENTAL
Intervention: IIV4-HD 60 µg
Number of subjects: 661

Group type: COMPARATOR
Intervention: IIV4-SD (15 µg HA/strain)
Number of subjects: 661

Group type: EXPERIMENTAL
Intervention: IIV4-HD
Number of subjects: 661
Study: 32466588

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) applied to both masseter muscles, 6.0–7.5 mA, 20 min per day, five times a week for six weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo NMES applied to both masseter muscles, 0.5 mA, 20 min per day, five times a week for six weeks
Number of subjects: 40
Study: 34263919

Group type: EXPERIMENTAL
Intervention: Cord clamping within 10 seconds (Group 1)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cord clamping at 60 seconds (Group 2)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Maternal and neonatal vitamin B12 levels correlation
Number of subjects: 60
Study: 34396803

Group type: EXPERIMENTAL
Intervention: Weight bearing exercises with tape (n=19)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Weight bearing exercises without tape (n=18)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group not engaged in weight bearing exercises (n=19)
Number of subjects: 56
Study: 32964468

Group type: EXPERIMENTAL
Intervention: Tell-us Card communication tool
Number of subjects: 265
Study: 35343725

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Relaxation group therapy (RGT)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: All groups (MBCT, RGT, TAU)
Number of subjects: 227
Study: 32991788

Group type: EXPERIMENTAL
Intervention: Aripiprazole (ARI) 10 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Olanzapine (OLA) 5 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Aripiprazole (ARI)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Olanzapine (OLA)
Number of subjects: 24
Study: 35148973

Group type: EXPERIMENTAL
Intervention: Micro-osteoperforation (MOP)
Number of subjects: 20
Study: 34088505

Group type: EXPERIMENTAL
Intervention: FD-subunit NAIIV4
Number of subjects: 320

Group type: COMPARATOR
Intervention: split-virion NAIIV4 (active control)
Number of subjects: 320

Group type: COMPARATOR
Intervention: HD-subunit NAIIV4 (control)
Number of subjects: 320
Study: 32205684

Group type: EXPERIMENTAL
Intervention: Epidural Fentanyl and Bupivacaine (10-mL solution of 50 mcg of Fentanyl, 0.125% Bupivacaine, and 0.9% saline solution)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Epidural Fentanyl and Bupivacaine
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (decompression alone)
Number of subjects: 45
Study: 36035303

Group type: EXPERIMENTAL
Intervention: CICARE communication model nursing intervention
Number of subjects: 102

Group type: COMPARATOR
Intervention: Routine doctor-patient communication nursing
Number of subjects: 102
Study: 34706426

Group type: EXPERIMENTAL
Intervention: ICD-11 guidelines
Number of subjects: 1357

Group type: COMPARATOR
Intervention: ICD-10 guidelines
Number of subjects: 1357
Study: 32628554

Group type: EXPERIMENTAL
Intervention: Low-Dose Rivaroxaban plus Aspirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 0
Study: 35758984

Group type: EXPERIMENTAL
Intervention: Creative expression program (intervention)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Education as usual (control)
Number of subjects: 120
Study: 34376181

Group type: EXPERIMENTAL
Intervention: Multi-component intervention (phone consultations, interactive phone application, pedometers)
Number of subjects: 375

Group type: COMPARATOR
Intervention: Usual diabetes care
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Multi-component intervention
Number of subjects: 375
Study: 35322396

Group type: EXPERIMENTAL
Intervention: Early rhythm control
Number of subjects: 62649

Group type: EXPERIMENTAL
Intervention: Early rhythm control (performed early <3 months)
Number of subjects: 62649

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 62649
Study: 32960053

Group type: EXPERIMENTAL
Intervention: BAY 1214784, an orally available spiroindoline derivative, administered once daily
Number of subjects: 0
Study: 32996592

Group type: EXPERIMENTAL
Intervention: Oral treatment with telapristone acetate (12 mg/day)
Number of subjects: 60
Study: 34241896

Group type: EXPERIMENTAL
Intervention: IANB + LLLT
Number of subjects: 88

Group type: COMPARATOR
Intervention: IANB
Number of subjects: 88
Study: 35550584

Group type: EXPERIMENTAL
Intervention: Lower-energy swaps offered
Number of subjects: 2150

Group type: EXPERIMENTAL
Intervention: Lower-energy swaps offered with PACE information
Number of subjects: 2150
Study: 32609979

Group type: EXPERIMENTAL
Intervention: Amoxicillin for 3 days
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Amoxicillin for 5 days
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 3000
Study: 33735146

Group type: EXPERIMENTAL
Intervention: MUSTCOOL cooling patch
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 140
Study: 32073955

Group type: EXPERIMENTAL
Intervention: Intensity-Modulated Radiotherapy (IMRT)
Number of subjects: 234
Study: 34219356

Group type: EXPERIMENTAL
Intervention: External hexagon connection (EHC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Internal hexagon connection (IHC)
Number of subjects: 20
Study: 33031356

Group type: EXPERIMENTAL
Intervention: lncRNAs in PD patients
Number of subjects: 55

Group type: COMPARATOR
Intervention: lncRNAs in healthy volunteers (controls)
Number of subjects: 55
Study: 36289399

Group type: EXPERIMENTAL
Intervention: Bamlanivimab 700 mg
Number of subjects: 271

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Bamlanivimab 7,000 mg
Number of subjects: 271
Study: 33882026

Group type: EXPERIMENTAL
Intervention: Multi-domain lifestyle interventions (6-month duration physical exercise, nutritional enrichment, cognitive training)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Multi-domain lifestyle interventions
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Active intervention
Number of subjects: 246

Group type: COMPARATOR
Intervention: Standard care control
Number of subjects: 246
Study: 32194255

Group type: EXPERIMENTAL
Intervention: Low pressure pneumoperitoneum (8 mmHg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard pressure pneumoperitoneum (12 and 16 mmHg)
Number of subjects: 30
Study: 35002538

Group type: EXPERIMENTAL
Intervention: Wrist-ankle acupuncture-moxibustion and hot compression with Chinese herbal medicine
Number of subjects: 82

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 82
Study: 32301992

Group type: EXPERIMENTAL
Intervention: Cardiovascular RCTs with multiplicity adjustment
Number of subjects: 511

Group type: COMPARATOR
Intervention: Cardiovascular RCTs without multiplicity adjustment
Number of subjects: 511

Group type: EXPERIMENTAL
Intervention: Trials assessing mortality outcomes
Number of subjects: 511

Group type: COMPARATOR
Intervention: Trials assessing nonmortality outcomes
Number of subjects: 511

Group type: EXPERIMENTAL
Intervention: Larger trials
Number of subjects: 511

Group type: COMPARATOR
Intervention: Smaller trials
Number of subjects: 511
Study: 32161004

Group type: EXPERIMENTAL
Intervention: cMNV3
Number of subjects: 102

Group type: COMPARATOR
Intervention: usual MNV3 without CRA
Number of subjects: 102
Study: 32532310

Group type: EXPERIMENTAL
Intervention: Ropivacaine 75 mg
Number of subjects: 272

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 272
Study: 35457744

Group type: EXPERIMENTAL
Intervention: Weight Watchers® Momentum™ (WW)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Curves® (CV) Fitness and Weight Management program
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 51
Study: 34474192

Group type: EXPERIMENTAL
Intervention: Energy-restricted Mediterranean Diet (er-MedDiet)
Number of subjects: 487
Study: 35125048

Group type: EXPERIMENTAL
Intervention: Total thoracic echogenicity intensity score (TTEI)
Number of subjects: 29
Study: 34255381

Group type: EXPERIMENTAL
Intervention: elbasvir/grazoprevir (EBR/GZR)
Number of subjects: 1609

Group type: EXPERIMENTAL
Intervention: ledipasvir/sofosbuvir (LDV/SOF)
Number of subjects: 1609

Group type: COMPARATOR
Intervention: Both EBR/GZR and LDV/SOF
Number of subjects: 1609
Study: 35999521

Group type: EXPERIMENTAL
Intervention: Flash dose of preoperative corticosteroids
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1200
Study: 34159691

Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT) with exercise
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Dry needling (DN) with exercise
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (exercise only)
Number of subjects: 88
Study: 33361239

Group type: EXPERIMENTAL
Intervention: Sharing Histories (SH) training method for community health workers (CHWs)
Number of subjects: 606

Group type: COMPARATOR
Intervention: Standard training methods for community health workers (CHWs)
Number of subjects: 606
Study: 32350819

Group type: EXPERIMENTAL
Intervention: Natural grazing resources available during summer
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Concentrate feed supplementation (86%) and tree foliage (92%) during winter
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Home-prepared concentrate feed by 87% of farmers
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Mineral mixture supplementation (6%)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Lack of technical know-how and winter feed scarcity
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Nutritional innovations and fodder conservation strategies suggested
Number of subjects: 63
Study: 35821536

Group type: EXPERIMENTAL
Intervention: Dietary intervention (18 nutritionist-led group sessions in the first year, then quarterly sessions throughout 8.5 years)
Number of subjects: 48535

Group type: COMPARATOR
Intervention: Usual diet comparison (written health-related materials only)
Number of subjects: 48535
Study: 32641470

Group type: EXPERIMENTAL
Intervention: Naproxen sodium 440 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Naproxen sodium 220 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Naproxen (both doses)
Number of subjects: 80
Study: 34809970

Group type: EXPERIMENTAL
Intervention: Myocardial injury after noncardiac surgery
Number of subjects: 394

Group type: COMPARATOR
Intervention: Prolonged surgery
Number of subjects: 394

Group type: COMPARATOR
Intervention: Need for transfusions
Number of subjects: 394

Group type: COMPARATOR
Intervention: Major adverse cardiac events
Number of subjects: 394

Group type: COMPARATOR
Intervention: Pulmonary complications
Number of subjects: 394

Group type: COMPARATOR
Intervention: Acute kidney injury
Number of subjects: 394

Group type: COMPARATOR
Intervention: Systemic inflammatory syndrome
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Survival up to 30 months after surgery
Number of subjects: 394
Study: 34582452

Group type: EXPERIMENTAL
Intervention: Antenatal malaria exposure (positive: 240 [57.3%])
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Maternal immune activation (increased maternal sTNFRII concentration)
Number of subjects: 421
Study: 35713449

Group type: EXPERIMENTAL
Intervention: Nalbuphine in patient-controlled intravenous analgesia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sufentanil
Number of subjects: 0
Study: 32427667

Group type: EXPERIMENTAL
Intervention: Social support for overcoming treatment-related challenges
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Racial differences in support needs and provision
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Resources within individual support networks
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Reliance on family/friends for cancer care
Number of subjects: 8
Study: 35871728

Group type: EXPERIMENTAL
Intervention: Nomogram predictive model for overall survival (OS) and cancer-specific survival (CSS) based on 5 variables: age, gender, WHO grades, surgery, and radiotherapy.
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Nomogram predictive model for OS and CSS in validation cohort.
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Calibration plots for OS and CSS.
Number of subjects: 369
Study: 34039479

Group type: EXPERIMENTAL
Intervention: Open-label trial for vaccination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonrandomized trial for parents willing to vaccinate their children
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonrandomized trial for parents hesitant to vaccinate their children
Number of subjects: 0
Study: 32887707

Group type: EXPERIMENTAL
Intervention: Sensor-augmented insulin pump therapy (SAP) for 1 year
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (multiple daily injection therapy)
Number of subjects: 26
Study: 36241128

Group type: EXPERIMENTAL
Intervention: eRAPID (weekly online symptom reporting for 12, 18 & 24 weeks)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 167
Study: 33914556

Group type: COMPARATOR
Intervention: Control writing condition
Number of subjects: 100
Study: 34755130

Group type: EXPERIMENTAL
Intervention: Oral immunotherapy (OIT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: OIT
Number of subjects: 0
Study: 32568096

Group type: EXPERIMENTAL
Intervention: Rosuvastatin (40 mg loading dose)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control (no statin)
Number of subjects: 125
Study: 34319247

Group type: EXPERIMENTAL
Intervention: SMS text messaging intervention (daily for the first 4 weeks, 5 messages on week 5, 3 messages each in weeks 6 and 7, and 1 message weekly from week 8 to week 52)
Number of subjects: 930

Group type: COMPARATOR
Intervention: Control group (monthly SMS text message reminding of next study appointment and importance of the study)
Number of subjects: 930
Study: 32155825

Group type: EXPERIMENTAL
Intervention: Sorafenib and nutrient-restriction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intermittent fasting with sorafenib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chloroquine with nutrient-restriction/sorafenib
Number of subjects: 0
Study: 35579641

Group type: EXPERIMENTAL
Intervention: Transcatheter Aortic Valve Implantation (TAVI)
Number of subjects: 913

Group type: COMPARATOR
Intervention: Surgical Aortic Valve Replacement (surgery)
Number of subjects: 913
Study: 33664081

Group type: EXPERIMENTAL
Intervention: 3.375‐4.5 g intravenous piperacillin‐tazobactam
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1‐2 g intravenous cefoxitin
Number of subjects: 0
Study: 32815891

Group type: EXPERIMENTAL
Intervention: Telephone-based administration of the ABILHAND
Number of subjects: 102

Group type: COMPARATOR
Intervention: Face-to-face administration of the ABILHAND
Number of subjects: 102
Study: 35821047

Group type: EXPERIMENTAL
Intervention: Heavyweight Sumo wrestlers
Number of subjects: 54

Group type: COMPARATOR
Intervention: Middleweight Sumo wrestlers
Number of subjects: 54
Study: 34168029

Group type: EXPERIMENTAL
Intervention: Artesunate-mefloquine (AM) - 3-day courses at 6-week intervals
Number of subjects: 0

Group type: COMPARATOR
Intervention: Praziquantel (PZQ) - single dose of 40 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Artesunate-mefloquine (AM)
Number of subjects: 0
Study: 34244991

Group type: EXPERIMENTAL
Intervention: ABRACADABRA reading programme (20 weeks of instruction in grapheme/phoneme knowledge, decoding, and comprehension)
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: ABRACADABRA reading programme
Number of subjects: 516

Group type: COMPARATOR
Intervention: Regular classroom instruction (control group)
Number of subjects: 516
Study: 32698957

Group type: EXPERIMENTAL
Intervention: Synbiotic supplement (109 CFU/day) for 8 weeks
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 76
Study: 32856168

Group type: COMPARATOR
Intervention: degarelix
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: unidimensional IRT model
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: bidimensional IRT model
Number of subjects: 403
Study: 36018050

Group type: EXPERIMENTAL
Intervention: Psychodrama sessions added to standard antenatal education
Number of subjects: 150

Group type: COMPARATOR
Intervention: Routine antenatal education classes (Control)
Number of subjects: 150
Study: 34842215

Group type: EXPERIMENTAL
Intervention: Integral Meditation (IM) program consisting of 12 weekly meditation classes after the afternoon shift
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Integral Meditation (IM) program
Number of subjects: 42
Study: 32605509

Group type: EXPERIMENTAL
Intervention: Lung cancer screening with low-dose computed tomography
Number of subjects: 45

Group type: COMPARATOR
Intervention: Health system 1
Number of subjects: 45

Group type: COMPARATOR
Intervention: Health system 2
Number of subjects: 45

Group type: COMPARATOR
Intervention: Health system 3
Number of subjects: 45
Study: 34928748

Group type: EXPERIMENTAL
Intervention: Cascading Model (CM)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Learning Collaborative (LC)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Distance Education (DE)
Number of subjects: 100
Study: 35124628

Group type: EXPERIMENTAL
Intervention: Single-incision, single-plate knee surgeries via antero-lateral approach
Number of subjects: 52

Group type: COMPARATOR
Intervention: Anterior median incisions of the knee for double-plate surgeries
Number of subjects: 52
Study: 36184194

Group type: EXPERIMENTAL
Intervention: Essential amino acid enriched meal replacement (EMR)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Optifast® (Control)
Number of subjects: 28
Study: 34582263

Group type: EXPERIMENTAL
Intervention: Automated ototoxicity monitoring (A‐OM) using Oto‐ID mobile audiometer
Number of subjects: 46

Group type: COMPARATOR
Intervention: Usual care (UC) ototoxicity monitoring
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Automated ototoxicity monitoring (A‐OM)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Both A‐OM and UC
Number of subjects: 46
Study: 33397017

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Aerobic Training (AT)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Control Group (C)
Number of subjects: 248
Study: 34184792

Group type: EXPERIMENTAL
Intervention: Turtle Program
Number of subjects: 151

Group type: COMPARATOR
Intervention: Cool Little Kids (CLK)
Number of subjects: 151
Study: 33941513

Group type: EXPERIMENTAL
Intervention: MV-for-all-policy
Number of subjects: 2778

Group type: COMPARATOR
Intervention: Restrictive-MV-policy
Number of subjects: 2778
Study: 32769526

Group type: EXPERIMENTAL
Intervention: ADSC-CM
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 36081227

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI) during pregnancy, comprising usual perinatal care and six digitally guided self-help MBI sessions
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual perinatal care (Control group)
Number of subjects: 80
Study: 34467631

Group type: EXPERIMENTAL
Intervention: PAC (Physical Activity Consultation) with standard care
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: PAC with structured exercise (EGII)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: PAC without structured exercise (EGI)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Control group (CG - standard care)
Number of subjects: 165
Study: 32683992

Group type: EXPERIMENTAL
Intervention: Monopolar dielectric diathermy by emission of radiofrequency (MDR) with 10 sessions over 3 weeks
Number of subjects: 84

Group type: COMPARATOR
Intervention: Home exercises (10 min daily for 3 weeks)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Monopolar dielectric diathermy by emission of radiofrequency (MDR)
Number of subjects: 84
Study: 35125067

Group type: EXPERIMENTAL
Intervention: Low-load exercise with blood-flow restriction (LL-BFR)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Low-load free-flow (LL-FF)
Number of subjects: 17
Study: 36186488

Group type: EXPERIMENTAL
Intervention: Nomogram model for predicting the risk of readmission in patients with HFrEF
Number of subjects: 0
Study: 32076468

Group type: EXPERIMENTAL
Intervention: Adaptive Support Ventilation (ASV)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Pressure Support Ventilation (PSV)
Number of subjects: 24
Study: 34916384

Group type: EXPERIMENTAL
Intervention: Hypofractionated radiotherapy (Arm A): 55 Gy in 20 fractions at 2.75 Gy per fraction, 5 days a week.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional radiotherapy (Arm B): 66 Gy in 33 fractions at 2 Gy per fraction, 5 days a week.
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Hypofractionated radiotherapy (Arm A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional radiotherapy (Arm B)
Number of subjects: 50
Study: 32155018

Group type: EXPERIMENTAL
Intervention: Topical combination therapy with 5% imiquimod cream, 2% 5-FU solution, and 0.1% tretinoin cream, applied five nights per week under occlusion for a treatment goal of 30 total applications.
Number of subjects: 1
Study: 32469406

Group type: EXPERIMENTAL
Intervention: Early ART initiation within 14 days from admission
Number of subjects: 82

Group type: COMPARATOR
Intervention: Delayed ART initiation until nutritional recovery and >14 days after admission
Number of subjects: 82
Study: 33355918

Group type: EXPERIMENTAL
Intervention: Proton beam therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard radiotherapy
Number of subjects: 0
Study: 32576275

Group type: EXPERIMENTAL
Intervention: Residential behavior therapeutic smoking cessation therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard outpatient behavior therapeutic smoking cessation group therapy
Number of subjects: 0